Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 2, Randomized, Placebo-Controlled, Double-Blind, Adaptive, Parallel Group Clinical Study to Evaluate the Efficacy and Safety of RMC-035 in Subjects at High Risk for Acute Kidney Injury Following Open-Chest Cardiac Surgery

Next Previous
Search
Trial Profile

A Phase 2, Randomized, Placebo-Controlled, Double-Blind, Adaptive, Parallel Group Clinical Study to Evaluate the Efficacy and Safety of RMC-035 in Subjects at High Risk for Acute Kidney Injury Following Open-Chest Cardiac Surgery

Status: Discontinued
Phase of Trial: Phase II

Latest Information Update: 05 Mar 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs RMC 035 (Primary)
  • Indications Acute kidney injury
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms AKITA
  • Sponsors Guard Therapeutics

    • Most Recent Events

    • 27 Feb 2025 Results presented in the Guard Therapeutics media release.
    • 17 Sep 2024 According to a Guard Therapeutics media release, the results of this study form the basis for the continued clinical development program with RMC-035 and the design of the recently initiated phase 2b POINTER study.
    • 17 Sep 2024 According to a Guard Therapeutics media release, the renowned scientific journal eClinicalMedicine, part of Lancet Discovery Science, has published an article describing the main findings from the company's phase 2 clinical study AKITA. This article was authored by Dr. Alexander Zarbock, the global principal investigator for the trial, and Professor of anesthesiology and intensive care medicine at the University Hospital of Munster, Germany.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top